EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Small molecule ligands for the melanocortin-4 receptor: pharmacology, biased signaling, and pharmacoperone potential

Ya-Xiong Tao, Ren-Lei Ji

Molecular and Cellular Endocrinology · 2026-11 · 621 · 112876

DOI: 10.1016/j.mce.2026.112876 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular and Cellular Endocrinology, 2026-11. Verfasst von Ya-Xiong Tao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL, 36849, USA. Electronic address: ta…. Hauptthemen laut MEDLINE: Receptor, Melanocortin, Type 4, Signal Transduction, Small Molecule Libraries. Die Arbeit nennt 149 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The melanocortin-4 receptor (MC4R) is a critical regulator of energy homeostasis, affecting both energy intake and expenditure. It is also involved in regulating reproduction. Recent clinical success with peptide agonists has validated MC4R as a therapeutically actionable target. However, orally active small-molecule ligands would offer important advantages over injectable peptides. Small-molecule agonists may provide therapeutic opportunities for obesity and sexual dysfunction, whereas small-molecule antagonists may have utility in cachexia, anorexia, and related wasting states. In addition, some hydrophobic small molecules can function as pharmacoperones, rescuing trafficking-defective naturally occurring MC4R mutations and thereby offering a precision medicine avenue for a subset of monogenic obesity. Moreover, some MC4R ligands display biased signaling properties, suggesting that pathway-selective modulation may further expand the pharmacological and therapeutic landscape of this receptor. In this review, we summarize the major classes of small-molecule ligands reported for MC4R, with emphasis on their pharmacology, biased signaling, and pharmacoperone activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Melanocortin, Type 4Signal TransductionSmall Molecule LibrariesHumansLigandsAnimals

Stichwörter der Autor:innen

Biased signalingCachexiaInverse agonistMelanocortin-4 receptorObesityPharmacoperoneSmall molecule

Substanzen

Receptor, Melanocortin, Type 4LigandsSmall Molecule Libraries

Autor:innen und Institutionen

  • Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL, 36849, USA. Electronic address: taoyaxi@auburn.edu.
  • Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL, 36849, USA.

Zitieren

APA

Tao, Y. X., & Ji, R. L. (2026). Small molecule ligands for the melanocortin-4 receptor: pharmacology, biased signaling, and pharmacoperone potential. Molecular and Cellular Endocrinology, 621, 112876. https://doi.org/10.1016/j.mce.2026.112876

Vancouver

Tao YX, Ji RL. Small molecule ligands for the melanocortin-4 receptor: pharmacology, biased signaling, and pharmacoperone potential. Molecular and Cellular Endocrinology. 2026;621:112876. doi:10.1016/j.mce.2026.112876

BibTeX
@article{Tao2026,
  author = {Tao, Ya-Xiong and Ji, Ren-Lei},
  title = {Small molecule ligands for the melanocortin-4 receptor: pharmacology, biased signaling, and pharmacoperone potential},
  journal = {Molecular and Cellular Endocrinology},
  year = {2026},
  volume = {621},
  pages = {112876},
  doi = {10.1016/j.mce.2026.112876}
}
Kostenlos starten →